Characterization of novel PI3Kδ inhibitors as potential therapeutics for SLE and lupus nephritis in pre-clinical studies

by Philipp eHaselmayer, Montserrat eCamps, Mathilde eMuzerelle, Mathilde eMuzerelle, Samer eEl Bawab, Caroline eWaltzinger, Caroline eWaltzinger, Lisa eBruns, Nada eAbla, Mark ePolokoff, Carole eJond-Necand, Marilène eGaudet, Audery eBenoit, Dominique eBertschy Meier, Catherine eMartin, Denise eGretener, Maria Stella Lombardi, Maria Stella Lombardi, Roland eGrenningloh, Christoph eLadel, Jørgen Søberg Petersen, Jørgen Søberg Petersen, Pascale eGaillard, Pascale eGaillard, Hong eJi, Hong eJi
Published 2014-05-01